If you need more lookups,
subscriptions start at $34 USD/month.
Bob Silverman Location
Red Bank, NJ, US
Bob Silverman Work
Vice President, Business Transactions @ (July 2025 - Present)
Chief Business Officer @ (September 2023 - April 2025)
Business Consultant to the CEO @ C2i Genomics (acquired by Veracyte Jan 2024) (July 2023 - December 2023)
Chief Business Officer @ C2i Genomics (January 2023 - June 2023)
Chief Business Officer @ (July 2021 - December 2022)
Executive Partner, 82VS; Chief Business Officer @ (August 2019 - July 2021)
Venture Capital Lead @ (September 2012 - June 2020)
Head Externalized Drug Discovery Partnering @ (August 2015 - December 2017)
Personalized Health Care (PHC) Business Strategy and Partnering @ Roche Diagnostics Division and Molecular Solutions (January 2018 - May 2020)
Director, Strategic Partnering @ (January 2010 - January 2012)
Global Licensing Director @ (January 2003 - January 2010)
Global Licensing Attorney @ (January 2001 - January 2003)
Senior Patent Counsel @ (January 1995 - January 2001)
Patent Attorney @ (January 1993 - January 1995)
Associate @ Pennie & Edmonds (January 1990 - January 1993)
Bob Silverman Education
Boston University School of Law
Juris Doctor
1987-1990
Franklin & Marshall College
Bachelor of Arts (B.A.) (Chemistry)
1983-1987
Monmouth Regional High School 1979-1983
Bob Silverman Skills
Pharmaceutical Industry
Biotechnology
Licensing
Oncology
Lifesciences
Regulatory Affairs
Venture Capital
R&D
Drug Development
Immunology
Patents
Biopharmaceuticals
Commercialization
Technology Transfer
Strategic Partnerships
Clinical Development
Molecular Biology
Drug Discovery
Chemistry
Medicinal Chemistry
Pharmaceutics
Biomarkers
Medical Devices
Biochemistry
Life Sciences
Leadership
Public Speaking
Sales
Project Management
Corporate Law
Strategic Planning
Intellectual Property
Bob Silverman Summary
Bob Silverman, based in Red Bank, NJ, US, is currently a Vice President, Business Transactions at Formation Bio. Bob Silverman brings experience from previous roles at Turbine, C2i Genomics (acquired by Veracyte Jan 2024), C2i Genomics and Rejuveron Life Sciences AG. Bob Silverman holds a 1987 - 1990 Juris Doctor @ Boston University School of Law. With a robust skill set that includes Pharmaceutical Industry, Biotechnology, Licensing, Oncology, Lifesciences and more. Bob Silverman has 1 emails and 5 mobile phone numbers on RocketReach.
Looking for a different Bob Silverman?
Find contact details for 700 million professionals.